Securities code: 688179 securities abbreviation: Shanghai Aladdin Biochemical Technology Co.Ltd(688179) Announcement No.: 2022-005
Shanghai Aladdin Biochemical Technology Co.Ltd(688179)
Announcement of resolutions of the 18th meeting of the third board of supervisors
The company and all members of the board of supervisors guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law. 1、 Meetings of the board of supervisors
Shanghai Aladdin Biochemical Technology Co.Ltd(688179) (hereinafter referred to as “the company”) convened the 18th meeting of the third board of supervisors of the company (hereinafter referred to as “the meeting”) by means of on-site combined communication on February 16, 2022. The notice of this meeting was sent to all supervisors in writing on February 11, 2022. There are 3 supervisors who should attend the meeting and 3 supervisors who actually attend the meeting. The meeting is presided over by Mr. Jiang Su, chairman of the board of supervisors of the company, and other relevant personnel of the company attend the meeting as nonvoting delegates. The convening and convening procedures of this meeting comply with relevant national laws and regulations, the articles of association and the rules of procedure of the board of supervisors. The convening procedures and voting results of this meeting are legal and valid. 2、 Deliberation at the meeting of the board of supervisors
The meeting was presided over by Mr. Jiang Su, chairman of the board of supervisors of the company. After voting by all supervisors, the following resolutions were formed: (I) the proposal on reserving and granting restricted shares to incentive objects was deliberated and adopted
1. The board of supervisors of the company checked whether the granting conditions of the company’s restricted stock incentive plan in 2021 (hereinafter referred to as “this incentive plan”) have been met, and held that:
The company is not prohibited to implement the equity incentive plan as stipulated in the administrative measures for equity incentive of listed companies and other laws, regulations and normative documents, and the company has the subject qualification to implement the equity incentive plan; The incentive objects reserved and granted in this incentive plan have the qualifications specified in the company law of the people’s Republic of China and other laws, regulations and normative documents, and meet the conditions of incentive objects specified in the measures for the administration of equity incentive of listed companies and the Listing Rules of science and Innovation Board of Shanghai Stock Exchange, It complies with the scope of incentive objects specified in the company’s 2021 restricted stock incentive plan (Draft) and its summary, and its subject qualification as the incentive object of the company’s 2021 restricted stock incentive plan is legal and effective.
2. The board of supervisors of the company checked the reserved grant date of the incentive plan and held that:
The company determines that the reserved grant date of this incentive plan complies with the relevant provisions on the grant date in the administrative measures for equity incentive of listed companies and the 2021 restricted stock incentive plan (Draft) and its abstract. Therefore, the board of supervisors agreed that the reserved grant date of the company’s incentive plan was February 16, 2022, and agreed to grant 250000 restricted shares to 29 incentive objects at the grant price of 40 yuan / share.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Announcement on reserving and granting restricted shares to incentive objects (Announcement No.: 2022-006).
Voting results: 3 in favor, 0 against and 0 abstention.
It is hereby announced.
Shanghai Aladdin Biochemical Technology Co.Ltd(688179) board of supervisors February 18, 2022
